Oncofactor
company
About
Oncofactor develops cancer therapeutics that disrupt signaling pathways between tumors and the immune system.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $2.10M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2011
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Oncofactor is a Seattle, Washington-based developer of cancer therapeutics that disrupt signaling pathways between tumors and the immune system.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$2.10M
Oncofactor has raised a total of
$2.10M
in funding over 2 rounds. Their latest funding was raised on
Aug 2, 2011 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 2, 2011 | Series A | $2.10M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Oncofactor is funded by 1 investors.
ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
